Ziprasidone Hydrochloride
Product Images NDC 55648-994

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ziprasidone Hydrochloride (NDC 55648-994). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ziprasidoncapsules M Figure 01)

FDA Label Image

Label (Ziprasidoncapsules M Figure 02)

This is a description of a medication capsule containing 20mg of ziprasidone hydrochloride monohydrate. The recommended dosage and usage is not provided and the accompanying prescribing information should be consulted. The capsule should be stored at room temperature. The medication is manufactured by Wockhardt Limited in Mumbai, India and distributed by Wockhardt USA LLC. The lot number and expiration date are not readable.*

FDA Label Image

Label (Ziprasidoncapsules M Figure 03)

FDA Label Image

Label (Ziprasidoncapsules M Figure 04)

FDA Label Image

Label (Ziprasidoncapsules M Figure 05)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.